2018 Health Professional
These are the current courses for 2019
ASCIA Anaphylaxis e-training for health professionals was updated July 2018 to include new generic versions of ASCIA Action Plans for Anaphylaxis. These plans have been developed for use with any brand of adrenaline (epinephrine) autoinjector available in Australia and New Zealand.
ASCIA anaphylaxis e-training for health professionals (AATHP) has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA) to provide ready access to reliable anaphylaxis education throughout Australia and New Zealand at no charge.
Development of ASCIA anaphylaxis e-training for health professionals has included an extensive review process involving ASCIA members and representatives from other medical organisations.
This has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA) and the National Allergy Strategy to provide ready access to accurate and consistent food allergy prevention education for health professionals throughout Australia and New Zealand, at no charge.
The course has included an extensive review process involving ASCIA members as well as representatives from other medical organisations throughout Australasia.
The aim of this course is to provide an evidence-based overview of eczema (atopic dermatitis) in children to promote accurate and consistent information for best practice management.
This course uses the term “eczema” to be consistent with resources for patients, consumers and carers.
Penicillin allergy is the most common drug allergy and is self-reported in up to 18 percent of hospitalised patients. However, most (up to 90%) of patients with a penicillin allergy label are found not to be allergic on further assessment. Importantly, in the true allergic patients, penicillin allergy can be life-threatening.
This course covers key questions about patients who have a history of penicillin allergy.